SIGMA Healthcare's planned rollout of pharmacy-based sleep testing services (PD 03 Mar) has reportedly alarmed sleep specialists who have branded it a "great example of poor medical practice".
According to an Australian Doctor report, Professor Eastwood, president of the Australian Sleep Association, said sleep apnoea was "a serious medical condition that requires serious care from trained professionals.
"These tests require a higher level of knowledge to interpret...pharmacists and GPs are not qualified," Eastwood said.
Amcal and Guardian pharmacies plan to roll out the $99 testing in partnership with Australian Pharmacy Sleep Services from next month, targeting the estimated 1.8 million undiagnosed Australians living with sleep apnoea.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 May 18
